Charity Search / MYELODYSPLASTIC SYNDROMES FOUNDATION
Diseases & Disorders (G30) IRS Verified DX Registered 990 on File

MYELODYSPLASTIC SYNDROMES FOUNDATION

EIN: 22-3283911 · NEW YORK, NY 10003-1502 · United States · FY 2024 Data
3 out of 5 46 / 100 Based on 2+ years of filings
Financial strength (30%) 66/100
Reliability (20%) 55/100
Effectiveness (25%) 61/100
Impact (25%) No data yet
Financial data: FY 2024 · Scored 9/13/2026
Claim this Charity
CharityAI™ Score
Not yet evaluated
Mission Statement

MDS Foundation supports and educates patients, their communities, and healthcare providers, and contributes to innovative research in the fields of MDS and its related continuum of diseases to better diagnose, control and ultimately cure these diseases.

Financial Overview — FY 2024
$2.0M
Total Revenue
$3.0M
Total Expenses
$3.6M
Net Assets
11
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio 64.8%
Fundraising Efficiency N/A
Operating Reserve 14.58x
Liability-to-Asset 6.7%
Revenue Diversification 97.3%
Executive Compensation $252K
Compared with Peers
FY 2024
Compared with 638 similar organizations (United States, Diseases & Disorders, $1M–$10M in expenses), FY 2024.
This organization Middle half of peers (P25–P75) Peer median
Ratio This org Peer median Position (P10 → P90)
Program expense ratio
Program expenses / total expenses · higher is better
64.8% 82.3%
P10P90
Bottom quarter
Admin expense ratio
Management and general / total expenses · lower is better
14.8% 11.5%
P10P90
Below median
Fundraising expense ratio
Fundraising expenses / total expenses · lower is better
20.4% 2.8%
P10P90
Bottom quarter
Operating reserve
Months of expenses covered by net assets · higher is better
14.6 mo 11.4 mo
P10P90
Above median
Liabilities to assets
Total liabilities / total assets · lower is better
6.7% 12.7%
P10P90
Above median
Revenue concentration
Share of revenue from the largest source · lower is better
97.3% 91.5%
P10P90
Below median
Revenue growth
Year over year revenue growth
-21.9% 9.6%
P10P90
Expense growth
Year over year expense growth
-10.8% 8.8%
P10P90
Surplus margin
Surplus as a share of revenue
-47.5% 2.2%
P10P90
Financial History
Year Revenue Expenses Net Assets Program % Staff
2024 $2.0M $3.0M $3.6M 64.8% 11
2023 $2.6M $3.3M $4.4M 75.3% 9
2022 $2.5M $2.2M $5.1M 81.4% 9
2021 $4.7M $2.8M $4.8M 88.0% 7
Donor Reviews
Write a Review
No reviews yet

Be the first to share your experience with this organization.


Write a Review
Minimum 20 characters
Reviews appear after moderation (usually within 24 hours)
Organization Details
EIN
22-3283911
State
NY
City
NEW YORK
ZIP
10003-1502
Classification
G30
Category
Diseases & Disorders
Rating
3★
Coverage
A
Last Updated
Aug 2026
IRS Ruling Year
1994
Foundation Code
15
Form 990
On File
Is this your organization?

Claim it to manage this profile, add your board, financials and impact metrics, and lift your CharityAI™ rating.

Claim this Charity
Back to Search New Search